Skip to main content Skip to section navigation Skip to footer
Bioscience Obesity
Our Company Pipeline Media & Investors Contact
Skye Bioscience, Inc. IR Overview
  • Investors
  • News
  • Company Info
    • Highlights
    • Corporate Presentation
    • IR Calendar/Webcasts
    • Executive Team
    • Email Alerts
    • Contacts
    • FAQ
  • Spotlight
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Analyst Coverage
    • Quote and Chart
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
  • Back to CorporateSite.com

News Releases

Investors

Investors

  • Overview
  • News
  • Company Info
    • Highlights
    • Corporate Presentation
    • IR Calendar/Webcasts
    • Executive Team
    • Email Alerts
    • Contacts
    • FAQ
  • Spotlight
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Analyst Coverage
    • Quote and Chart
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
Oct 7, 2021 9:00 am EDT
Skye Bioscience Appoints Head of Regulatory Affairs & Quality Assurance and Senior Director of Research & Development

Oct 5, 2021 8:30 am EDT
Skye Bioscience Appoints Kaitlyn Arsenault as Chief Financial Officer

Sep 29, 2021 4:30 pm EDT
Skye Bioscience Announces Closing of $7.0 Million Registered Direct Offering

Sep 27, 2021 9:30 am EDT
Skye Bioscience Announces $7.0 Million Registered Direct Offering

Sep 21, 2021 9:00 am EDT
Skye Bioscience Announces THCVHS Late-Breaking Preclinical Abstracts Selected by American Association of Pharmaceutical Scientists Meeting PharmSci 360

Sep 14, 2021 8:59 am EDT
Skye Bioscience Announces Special Virtual Investor Presentation

Sep 7, 2021 8:30 am EDT
Skye Bioscience to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Aug 11, 2021 8:30 am EDT
Skye Bioscience to Present at the H.C. Wainwright Ophthalmology Conference

Aug 10, 2021 8:30 am EDT
Skye Bioscience Completes THCVHS IND-enabling In Vitro Genotoxicity Studies

Jul 26, 2021 8:30 am EDT
Skye Bioscience Appoints Biotech Executive Praveen Tyle, Ph.D. to Board of Directors

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • …
  • Page 23
  • Next Pagearrow_forward
rss_feed News RSS
  • emailEmail Alerts
  • location_cityCompany Profile
  • contact_pageContacts
  • account_treeSitemap
11250 El Camino Real, Suite 100
San Diego, CA 92130
info@skyebioscience.com
Company
Our Company Careers Investors Contact
Product
Obesity
Media
News
© 2025 Skye Bioscience.
All Rights Reserved.
Terms of use Privacy Policy
Facebook Twitter LinkedIn